Reshoring efforts in US FMCG business begins, but cost increases are likely
US-based multinational Johnson & Johnson (J&J) has announced that it will be investing $55bn in new US manufacturing facilities over…
US-based multinational Johnson & Johnson (J&J) has announced that it will be investing $55bn in new US manufacturing facilities over…
API peptides and protein-based drugs are promising therapeutics for the treatment of a variety of metabolic and oncological disorders. More…
Pfizer recently announced an agreement to acquire Seagen, a biotech company based in the US with four marketed oncology therapeutic…
In recent years, with the advent of biologics and novel therapeutic targets such as anti-TNF, anti-interleukin, and anti-integrin, there has…
GlobalData is pleased to be attending the Professional Society for Health Economics and Outcomes Research (ISPOR) Europe Conference from 6–9…
The rate of biosimilar adoption for the treatment of autoimmune diseases varies greatly by geographical market. In 2018 and 2020,…
Chronic hepatitis B (CHB) is a viral liver disease that develops when the immune system cannot fight the hepatitis B…
Despite the alarming spike in new cases with India’s second wave, there is simply not enough evidence to place blame…
Bunge Loders Croklaan, an oils and fat solutions provider for the global food industry, unveiled a new lipid ingredient called…
The Covid-19 pandemic has led to the closure of schools and colleges across the world to contain the spread of…